The novel cGAS inhibitor screening assay from Cayman Chemical provides as easy-to-use tool to identify novel inhibitors of human cGAS. Inhibition of cGAS activity can decrease type I IFN production, providing a potential treatment for autoimmune diseases, whilst promoting cGAS activity may have therapeutic anti-tumour applications. The kit offers high sensitivity to detect both potent and weak test compounds, ideal for profiling entire compound libraries to discover unknown modulators, and provides results in just 3 hours.
Benefits of using the cGAS inhibitor screening assay
• Discover modulators of cGAS activity
• Easy-to-use tool
• Provided complete with all optimised components
• High sensitivity to detect both potent and weak compounds
• Results in just 3 hours
Development and validation of a novel cGAS inhibitor screening assay
Assay schematic
Applications
• Innate immunity research
• Autoimmunity research
• Cancer researcher
Products
Note: product availability depends on country - see product detail page.
| Details | Cat number & supplier | Size | Price |
| cGAS Inhibitor Screening Assay Kit CAY701930-96 solid wells · Cayman Chemical | CAY701930-96 solid wells Cayman Chemical |
96 solid wells |
£783.00
96 solid wells
view
|
| cGAS Inhibitor Screening Assay Kit CAY701930-96 strip wells · Cayman Chemical | CAY701930-96 strip wells Cayman Chemical |
96 strip wells |
£783.00
96 strip wells
view
|
